UNSPSC 51351511: Megestrol acetate

This classification denotes a therapeutic progestin with the molecular formula C24H32O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TJ2M0FR8ES, chemically known as pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl- but generally known as megestrol acetate, which bears US NIH Compound Identifier 4048. European Medicines Agency schedules Megestrol acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03117MIG. Most nations schedule megestrol acetate under HS 29372300 and SITC 54153.

As of Q4 2014, MEGESTROL ACETATE remains the US FDA Preferred Term for this commodity. Megestrol acetate bears US NLM identifiers UMLS ID C0065879 and NCI Concept Code C1156. SMILES: O(C1(C2(C(C3C(CC2)C2(C(=CC(=O)CC2)C(=C3)C)C)CC1)C)C(=O)C)C(=O)C.

UNSPSC 51351511 Megestrol acetate, a Commodity code, encompasses the procurement of megestrol acetate, a synthetic progestin used primarily as an appetite stimulant and for treatment of certain hormone-responsive conditions in medical and veterinary settings. State and local governments purchase megestrol acetate through healthcare agencies, corrections departments, and public health systems to support inpatient and outpatient clinical protocols, long-term care facilities, and institutional pharmacy operations. Issuing bodies include state departments of health, county health departments, municipal hospitals, state prison systems, and regional medical centers that stock the medication for routine dispensing, chronic disease management, and specialized treatment programs.

The source provides no recent state and local contract opportunities tagged to this Commodity code, limiting visibility into current geographic concentration, active issuing bodies, or representative procurement patterns. Without posted solicitations, the code shows no identifiable activity in the recent state and local procurement market. Firms evaluating this code should monitor state health department RFPs, corrections-system cooperative purchasing catalogs, and multi-hospital group purchasing organization addenda for megestrol acetate supply or wholesale pharmaceutical contracts, which may classify the product under related pharmaceutical supply codes rather than this narrow Commodity designation.